SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 131 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,082,000 | -50.7% | 43,081 | -38.9% | 0.61% | -59.2% |
Q3 2014 | $2,194,000 | +23.6% | 70,542 | +2.8% | 1.50% | +25.5% |
Q2 2014 | $1,775,000 | +17.1% | 68,654 | +5.9% | 1.20% | +11.4% |
Q1 2014 | $1,516,000 | +7.4% | 64,856 | +16.6% | 1.07% | -10.3% |
Q4 2013 | $1,412,000 | – | 55,619 | – | 1.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |